334 related articles for article (PubMed ID: 22683711)
1. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.
Groesser L; Herschberger E; Ruetten A; Ruivenkamp C; Lopriore E; Zutt M; Langmann T; Singer S; Klingseisen L; Schneider-Brachert W; Toll A; Real FX; Landthaler M; Hafner C
Nat Genet; 2012 Jun; 44(7):783-7. PubMed ID: 22683711
[TBL] [Abstract][Full Text] [Related]
2. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
Groesser L; Herschberger E; Sagrera A; Shwayder T; Flux K; Ehmann L; Wollenberg A; Torrelo A; Bagazgoitia L; Diaz-Ley B; Tinschert S; Oschlies I; Singer S; Mickler M; Toll A; Landthaler M; Real FX; Hafner C
J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891
[TBL] [Abstract][Full Text] [Related]
3. [MAP-kinase pathway activation in nevus sebaceous and Schimmelpenning syndrome].
Dereure O
Ann Dermatol Venereol; 2013 Apr; 140(4):326-7. PubMed ID: 23567237
[No Abstract] [Full Text] [Related]
4. Cutaneous Skeletal Hypophosphatemia Syndrome in Association with a Mosaic
Park PG; Park E; Hyun HS; Kang HG; Ha IS; Cho TJ; Ko JM; Cheong HI
Ann Clin Lab Sci; 2018 Sep; 48(5):665-669. PubMed ID: 30373874
[TBL] [Abstract][Full Text] [Related]
5. Schimmelpenning-Feuerstein-Mims syndrome induced by HRAS Gly12Ser somatic mosaic mutation: Case report and literature review.
Ono H; Yamaguchi R; Arai M; Togi S; Ura H; Niida Y; Shimizu A
J Dermatol; 2023 Sep; 50(9):1213-1215. PubMed ID: 37170693
[TBL] [Abstract][Full Text] [Related]
6. A postzygotic KRAS mutation in a patient with Schimmelpenning syndrome presenting with lipomatosis, renovascular hypertension, and diabetes mellitus.
Nagatsuma M; Takasawa K; Yamauchi T; Nakagawa R; Mizuno T; Tanaka E; Yamamoto K; Uemura N; Kashimada K; Morio T
J Hum Genet; 2019 Feb; 64(2):177-181. PubMed ID: 30443000
[TBL] [Abstract][Full Text] [Related]
7. A Patient With Schimmelpenning Syndrome and Mosaic KRAS Mutation.
Mitchell BJ; Rogers GF; Wood BC
J Craniofac Surg; 2019 Jan; 30(1):184-185. PubMed ID: 30394973
[TBL] [Abstract][Full Text] [Related]
8. Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceus.
Levinsohn JL; Tian LC; Boyden LM; McNiff JM; Narayan D; Loring ES; Yun D; Sugarman JL; Overton JD; Mane SM; Lifton RP; Paller AS; Wagner AM; Antaya RJ; Choate KA
J Invest Dermatol; 2013 Mar; 133(3):827-830. PubMed ID: 23096712
[No Abstract] [Full Text] [Related]
9. Is Schimmelpenning Syndrome Associated with Intracranial Tumors? A Case Report.
Chiang MC; McDowell MM; Weaver K; Broniscer A; Greene S
Pediatr Neurosurg; 2019; 54(3):201-206. PubMed ID: 30879010
[TBL] [Abstract][Full Text] [Related]
10. Novel postzygotic KRAS mutation in a Japanese case of epidermal nevus syndrome presenting with two distinct clinical features, keratinocytic epidermal nevi and sebaceous nevi.
Igawa S; Honma M; Minami-Hori M; Tsuchida E; Iizuka H; Ishida-Yamamoto A
J Dermatol; 2016 Jan; 43(1):103-4. PubMed ID: 26498739
[No Abstract] [Full Text] [Related]
11. Systematised naevus sebaceus resulting from post-zygotic mutation in HRAS.
Hsu CK; Saito R; Nanda A; Rashidghamat E; Al-Ajmi H; Lee JY; Hide M; McGrath JA
Australas J Dermatol; 2017 Feb; 58(1):58-60. PubMed ID: 26400620
[TBL] [Abstract][Full Text] [Related]
12. Naevus sebaceus: a mosaic RASopathy.
Aslam A; Salam A; Griffiths CE; McGrath JA
Clin Exp Dermatol; 2014 Jan; 39(1):1-6. PubMed ID: 24341474
[TBL] [Abstract][Full Text] [Related]
13. Mosaic activating RAS mutations in nevus sebaceus and nevus sebaceus syndrome.
Sun BK; Saggini A; Sarin KY; Kim J; Benjamin L; LeBoit PE; Khavari PA
J Invest Dermatol; 2013 Mar; 133(3):824-827. PubMed ID: 23096709
[No Abstract] [Full Text] [Related]
14. Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies.
Chacon-Camacho OF; Lopez-Moreno D; Morales-Sanchez MA; Hofmann E; Pacheco-Quito M; Wieland I; Cortes-Gonzalez V; Villanueva-Mendoza C; Zenker M; Zenteno JC
Mol Genet Genomic Med; 2019 May; 7(5):e625. PubMed ID: 30891959
[TBL] [Abstract][Full Text] [Related]
15. Pigmented trichoblastoma developed in a sebaceous nevus: HRAS mutation as a common molecular driver.
Saraggi D; Salmaso R; Valentini E; Munari G; Vindigni V; Rugge M; Fassan M; Cerroni L
Pathol Res Pract; 2017 Jul; 213(7):860-862. PubMed ID: 28554764
[TBL] [Abstract][Full Text] [Related]
16. Phacomatosis pigmentokeratotica: Postzygotic HRAS mutation with malignant degeneration of the sebaceous naevus.
Cranwell WC; Walsh M; Winship I
Australas J Dermatol; 2019 Aug; 60(3):e245-e246. PubMed ID: 30767209
[No Abstract] [Full Text] [Related]
17. Nevus sebaceus is a mosaic RASopathy.
Happle R
J Invest Dermatol; 2013 Mar; 133(3):597-600. PubMed ID: 23399824
[TBL] [Abstract][Full Text] [Related]
18. Discordance for Schimmelpenning-Feuerstein-Mims syndrome in monochorionic twins supports the concept of a postzygotic mutation.
Rijntjes-Jacobs EG; Lopriore E; Steggerda SJ; Kant SG; Walther FJ
Am J Med Genet A; 2010 Nov; 152A(11):2816-9. PubMed ID: 20949522
[TBL] [Abstract][Full Text] [Related]
19. Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcoma.
Bourdeaut F; Hérault A; Gentien D; Pierron G; Ballet S; Reynaud S; Paris R; Schleiermacher G; Baumann C; Philippe-Chomette P; Gauthier-Villars M; Peuchmaur M; Radvanyi F; Delattre O
J Med Genet; 2010 Dec; 47(12):859-62. PubMed ID: 20805368
[TBL] [Abstract][Full Text] [Related]
20. Giant syringocystadenocarcinoma papilliferum with conjunctival recurrence: Possible Schimmelpenning syndrome with postzygotic G13R HRAS and K601N BRAF signature.
Dupont A; Vergara R; Pacaud A; Dequidt L; Dutriaux C; Saunier V; Caumont C; Jullie ML; Taïeb A; Morice-Picard F; Dousset L
J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):e1420-e1422. PubMed ID: 37458522
[No Abstract] [Full Text] [Related]
[Next] [New Search]
